Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...

Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.

This concealer is the best I've tried so far. My skin is textured and tends to be dry in the colder months, so I appreciate ...

In an era where software development costs continue to rise, organizations can't afford the luxury of building first and ...

Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...

The blueprint for app development successDiscover the four foundational pillars to creating mobile apps that stand out and deliver impact. By Lloyd Hendricks, Practice head of mobile services, ...

The Senate Budget Committee will take the first step Wednesday toward enacting a partisan border security, defense and energy package.

Discover the transformative power of circular agriculture, redefining waste as opportunity and paving the way for sustainable ...

If you’ve been on the internet recently, you’ve likely encountered Bryan Johnson’s meticulously optimized, data-driven quest ...

A new documentary tells the story of a company of Black Emergency Medical Services (EMS) workers, and how their efforts ...